Michael Dudley

Michael Dudley has extensive experience in the healthcare industry, with a focus on oncology and medical device sales and marketing. Michael is currently the Co-Founder, CEO, and Director of TransCode Therapeutics, Inc., a company that specializes in RNA Oncology and aims to improve cancer diagnostics and personalized treatment options. Prior to this, Dudley co-founded Artemes Technologies, Inc. and served as the CEO and Co-Founder of Aygion, Inc. Michael also founded Medchannel, LLC, where they held positions as Chairman and CEO. Dudley's earlier experience includes serving as the Vice President of Sales and Marketing at Onux Medical Inc, where they managed a team and oversaw strategic sales and marketing efforts. Overall, Dudley has a strong background in founding and leading healthcare companies, with a focus on innovative diagnostics and therapeutics in the oncology field.

Michael Dudley obtained a Bachelor of Science degree with a focus in Biology and an emphasis in Immunology from Kent State University. No specific start or end years were mentioned.